This website uses cookies to enhance the user experience.
R

ROBERT EIDISSEN AS932 913 763

Limited company
Bråvoldvegen 3B 3660 RJUKAN, Norge

ROBERT EIDISSEN AS

Organization

Chairman of the board
Years since formation
1 year
since Jan 29, 2024
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
49
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2024
215,254
NOK
Total equity 2024
5,154,953
NOK
Last update: May 28, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Others

NameRoleShares
W
WÆRP REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Nov 21, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
49
100 %

Shares owned by the ROBERT EIDISSEN AS

NameShare classTotal number of sharesShare
S
SCANA ASA
NO0003053308
200,000
0.04 %
L
LYTIX BIOPHARMA AS
NO0010405780
26,500
0.04 %
D
DNO ASA
NO0003921009
75,000
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024
Total operating income
0
Annual Total Result
215,254
Total assets
5,180,253
Total liabilities
25,300
Total equity
5,154,953

P&L

Year2024
Total operating income
0
Total operating costs
24,164
Operating result
-24,164
Financial income/costs
264,718
Profit before tax
240,554
Total tax & extraordinary income/cost
25,300
Annual Total Result
215,254

Balance overview

Year2024
Total fixed assets
0
Total current assets
5,180,253
Total assets
5,180,253
Short term debt
25,300
Long term debt
0
Total liabilities
25,300
Contributed capital
4,939,699
Retained earnings
215,254
Total equity
5,154,953
Total equity and liabilities
5,180,253

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises